[New antibiotics: do we need new molecules or new strategies?].
Even though the situation in the field of research and development of new antimicrobial agents is not ideal, the years of stagnation, especially among anti-gramnegative agents, seem to be over. During the years 2011-2012 we have witnessed a movement towards a development of some new antibiotic agents not only with anti-gramposi-tive activity but with anti-gramnegative too, as well as new antituberculotics and antifungals. Here we present some of these new antiinfectives, presented in conferences during the last year, of which many are being shifted to the level of clinical trials of phase II-III, while others are in stage of preclinical studies. antibiotics - antimycotics - antituberculotics.